Morgan Stanley maintains Overweight on McGraw Hill, cuts target to $18
Morgan Stanley analyst Toni Kaplan maintains an Overweight rating on McGraw Hill but reduces the price target to $18 from $21, reflecting a revised valuation outlook while retaining a positive performance expectation relative to peers.

*this image is generated using AI for illustrative purposes only.
Morgan Stanley analyst Toni Kaplan has maintained an Overweight rating on McGraw Hill while lowering the price target to $18 from $21. The revised target indicates a recalibrated valuation outlook for the company's shares.
The decision to lower the price target comes as the firm assesses McGraw Hill's current market position and future performance potential. Despite the reduction in the target price, the Overweight rating suggests that the stock is still expected to outperform relative to its sector peers.
Rating and Price Target Details
The following table outlines the revised ratings and price targets provided by Morgan Stanley:
| Metric | Value |
|---|---|
| Rating | Overweight |
| Previous Price Target | $21 |
| New Price Target | $18 |
The adjustment in the price target highlights the firm's updated analysis, while the continued Overweight stance signals confidence in the company's fundamental strength.
What specific factors led Morgan Stanley to recalibrate McGraw Hill's valuation outlook?
How might McGraw Hill's future performance potential differ from its sector peers?
What market conditions could influence McGraw Hill's ability to maintain its Overweight rating?


























